Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo F Martelli

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Seminars in Hematology|October 30, 2016
Haploidentical transplants using ex vivo T-cell depletionMassimo F Martelli, Franco Aversa
Springer Seminars in Immunopathology|September 21, 2004
Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseasesFranco Aversa, Massimo F Martelli
Blood Cells, Molecules & Diseases|November 6, 2007
From 'megadose' haploidentical hematopoietic stem cell transplants in acute leukemia to tolerance induction in organ transplantationYair Reisner, Massimo F Martelli
Blood Cells, Molecules & Diseases|November 6, 2004
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemiaFranco Aversa, Yair Reisner, Massimo F Martelli
Blood Cells, Molecules & Diseases|October 2, 2007
The haploidentical option for high-risk haematological malignanciesFranco Aversa, Yair Reisner, Massimo F Martelli
Seminars in Oncology|December 5, 2012
Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunityFranco Aversa, Massimo F Martelli, Andrea Velardi
Blood|September 17, 2011
Haploidentical hematopoietic transplantation: current status and future perspectivesYair Reisner, David Hagin, Massimo F Martelli
Blood|September 30, 2006
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical featuresBrunangelo Falini, Ildo Nicoletti, Massimo F Martelli, et al.
Immunological Reviews|November 15, 2006
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing selfLoredana Ruggeri, Franco Aversa, Massimo F Martelli, et al.
Current Opinion in Immunology|March 16, 2005
Exploitation of alloreactive NK cells in adoptive immunotherapy of cancerLoredana Ruggeri, Antonella Mancusi, Marusca Capanni, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Seminars in Hematology|October 30, 2016
Haploidentical transplants using ex vivo T-cell depletionMassimo F Martelli, Franco Aversa
Springer Seminars in Immunopathology|September 21, 2004
Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseasesFranco Aversa, Massimo F Martelli
Blood Cells, Molecules & Diseases|November 6, 2007
From 'megadose' haploidentical hematopoietic stem cell transplants in acute leukemia to tolerance induction in organ transplantationYair Reisner, Massimo F Martelli
Blood Cells, Molecules & Diseases|November 6, 2004
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemiaFranco Aversa, Yair Reisner, Massimo F Martelli
Blood Cells, Molecules & Diseases|October 2, 2007
The haploidentical option for high-risk haematological malignanciesFranco Aversa, Yair Reisner, Massimo F Martelli
Seminars in Oncology|December 5, 2012
Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunityFranco Aversa, Massimo F Martelli, Andrea Velardi
Blood|September 17, 2011
Haploidentical hematopoietic transplantation: current status and future perspectivesYair Reisner, David Hagin, Massimo F Martelli
Blood|September 30, 2006
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical featuresBrunangelo Falini, Ildo Nicoletti, Massimo F Martelli, et al.
Immunological Reviews|November 15, 2006
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing selfLoredana Ruggeri, Franco Aversa, Massimo F Martelli, et al.
Current Opinion in Immunology|March 16, 2005
Exploitation of alloreactive NK cells in adoptive immunotherapy of cancerLoredana Ruggeri, Antonella Mancusi, Marusca Capanni, et al.
Pageof 8